pindolol has been researched along with Behavior Disorders in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, V | 1 |
| Meurice, E | 1 |
| Remy-Schmetz, J | 1 |
| Denys, WJ | 1 |
| Spruyt, L | 1 |
2 other studies available for pindolol and Behavior Disorders
| Article | Year |
|---|---|
[Therapeutic combination of psychopharmacoenticals and beta-sympathicolytics].
Topics: Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Mental Disorders; Pindolol; Psychotropi | 1976 |
[Preliminary trial of a beta-blocking agent (pindolol) in 3 schizophrenic patients and 3 non-psychotic psychiatric patients. Difference in sensitivity of heart rate].
Topics: Adult; Antisocial Personality Disorder; Bradycardia; Chronic Disease; Drug Evaluation; Heart Rate; H | 1974 |